CVAC
CureVac NV
Price:  
3.20 
USD
Volume:  
315,412.00
Germany | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CVAC WACC - Weighted Average Cost of Capital

The WACC of CureVac NV (CVAC) is 9.3%.

The Cost of Equity of CureVac NV (CVAC) is 9.30%.
The Cost of Debt of CureVac NV (CVAC) is 8.55%.

Range Selected
Cost of equity 8.10% - 10.50% 9.30%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 4.50% - 12.60% 8.55%
WACC 7.9% - 10.6% 9.3%
WACC

CVAC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.92 1.01
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.10% 10.50%
Tax rate 0.10% 0.20%
Debt/Equity ratio 0.06 0.06
Cost of debt 4.50% 12.60%
After-tax WACC 7.9% 10.6%
Selected WACC 9.3%